Sang Yoon Kim Selected Research

Sang Yoon Kim Research Topics

Disease

143	Neoplasms (Cancer) 07/2022 - 10/2003
41	Squamous Cell Carcinoma of Head and Neck 01/2021 - 04/2002
38	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2006
22	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 10/2003
16	Carcinoma (Carcinomatosis) 01/2019 - 11/2005
13	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 09/2006
11	Hypoxia (Hypoxemia) 01/2021 - 08/2005
11	Extranodal Extension 01/2020 - 04/2014
8	Papillary Thyroid Cancer 02/2022 - 04/2014
8	Breast Neoplasms (Breast Cancer) 11/2018 - 08/2005
7	Lymphatic Metastasis 01/2020 - 09/2012
6	Body Weight (Weight, Body) 01/2020 - 01/2013
6	Hypoalbuminemia 12/2018 - 06/2011
5	Hypopharyngeal Neoplasms 07/2022 - 01/2012
5	Deglutition Disorders (Dysphagia) 07/2022 - 08/2009
5	Carcinogenesis 01/2021 - 05/2005
5	Laryngeal Neoplasms (Laryngeal Cancer) 07/2018 - 06/2013
4	Salivary Gland Neoplasms (Salivary Gland Cancer) 05/2015 - 02/2007
4	Nasopharyngeal Carcinoma 05/2008 - 03/2005
3	Fistula 12/2022 - 10/2006
3	Inflammation (Inflammations) 05/2022 - 01/2002
3	Paralysis (Palsy) 03/2022 - 03/2002
3	Hypothyroidism 02/2022 - 12/2018
3	Myocardial Infarction 01/2020 - 10/2014
3	Margins of Excision 01/2020 - 01/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2017 - 11/2005
3	Necrosis 07/2017 - 10/2006
3	Hemorrhage 02/2017 - 05/2008
3	Prognathism 01/2016 - 12/2013
3	Lung Neoplasms (Lung Cancer) 03/2015 - 11/2005
3	Tongue Neoplasms (Tongue Neoplasm) 01/2015 - 01/2009
3	Melanoma (Melanoma, Malignant) 12/2009 - 02/2008
2	Thrombosis (Thrombus) 01/2022 - 06/2007
2	Triple Negative Breast Neoplasms 01/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

23	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2020 - 02/2007
20	Pharmaceutical PreparationsIBA 01/2022 - 05/2005
19	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2008
17	Heparin (Liquaemin)FDA LinkGeneric 09/2017 - 09/2006
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2005
10	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 09/2006
9	Caspase 3 (Caspase-3)IBA 01/2022 - 04/2013
9	ProdrugsIBA 01/2019 - 02/2015
9	Angiogenesis InhibitorsIBA 04/2016 - 12/2008
8	FluorineIBA 01/2020 - 04/2014
8	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 04/2016 - 06/2009
7	Therapeutic UsesIBA 01/2016 - 02/2008
6	AlbuminsIBA 01/2022 - 01/2016
6	Peptides (Polypeptides)IBA 01/2022 - 11/2007
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016 - 12/2009
6	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2007 - 04/2002
5	AnticoagulantsIBA 01/2021 - 06/2009
5	Deoxycholic Acid (Sodium Deoxycholate)IBA 10/2017 - 04/2007
5	Indicators and Reagents (Reagents)IBA 09/2017 - 02/2015
5	Taurocholic Acid (Sodium Taurocholate)IBA 04/2016 - 06/2012
4	Cytotoxins (Cytolysins)IBA 01/2022 - 07/2018
4	CaspasesIBA 10/2021 - 02/2011
4	Serum AlbuminIBA 12/2018 - 02/2016
4	PolymersIBA 10/2017 - 02/2007
4	Poloxamer (Poloxamer 407)IBA 10/2017 - 12/2010
4	Paclitaxel (Taxol)FDA LinkGeneric 02/2012 - 04/2009
4	Desoxycorticosterone Acetate (DOCA)FDA Link 12/2010 - 09/2006
3	IntegrinsIBA 01/2022 - 11/2012
3	Messenger RNA (mRNA)IBA 01/2022 - 03/2014
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2008
3	IodineIBA 10/2020 - 01/2015
3	Sirolimus (Rapamycin)FDA Link 01/2019 - 07/2013
3	LigandsIBA 01/2019 - 04/2014
3	DNA (Deoxyribonucleic Acid)IBA 07/2018 - 08/2005
3	Cyclin D1IBA 07/2017 - 08/2005
3	CateninsIBA 01/2016 - 04/2013
3	Docetaxel (Taxotere)FDA Link 10/2015 - 01/2013
3	Cisplatin (Platino)FDA LinkGeneric 10/2015 - 03/2005
3	Celecoxib (Celebrex)FDA Link 07/2015 - 05/2005
3	dimethyl sulfone (methylsulfonylmethane)IBA 06/2015 - 01/2012
3	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 10/2012 - 01/2009
3	Erythropoietin Receptors (Erythropoietin Receptor)IBA 10/2012 - 06/2008
3	Deoxyglucose (2 Deoxy D glucose)IBA 10/2012 - 04/2005
3	glycol-chitosanIBA 02/2012 - 10/2007
2	Retinaldehyde (Retinal)IBA 07/2022 - 01/2022
2	CytokinesIBA 01/2021 - 01/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 06/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 04/2014

Therapy/Procedure

58	Therapeutics 07/2022 - 03/2005
46	Radiotherapy 01/2022 - 03/2005
23	Neck Dissection (Radical Neck Dissection) 10/2020 - 02/2006
18	Chemoradiotherapy 01/2020 - 02/2011
17	Drug Therapy (Chemotherapy) 01/2022 - 02/2007
12	Aftercare (After-Treatment) 07/2022 - 02/2007
10	Thyroidectomy 10/2020 - 07/2007
6	Laryngectomy 01/2022 - 02/2006
6	Oral Administration 11/2017 - 05/2008
5	Tracheostomy 01/2022 - 01/2016
5	Salvage Therapy 09/2019 - 01/2016
4	Osteotomy 07/2014 - 12/2013
4	Microspheres (Microsphere) 08/2006 - 01/2002
3	Laryngoplasty 03/2022 - 03/2002
3	Injections 10/2017 - 08/2006
3	Induction Chemotherapy 10/2015 - 09/2011
3	Chemoprevention 02/2015 - 05/2005
2	Immunotherapy 01/2021 - 01/2019